Fidelity Investments
DERM icon

Fidelity Investments’s Journey Medical DERM Stock Holding History

Fidelity Investments’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.37K Sell
476
-1,718
-78% -$9.81K ﹤0.01% 5088
2026
Q1 		$10.3K Buy
2,194
+1,998
+1,019% +$15.5K ﹤0.01% 4760
2025
Q4 		$1.51K Buy
196
+177
+932% +$1.39K ﹤0.01% 5050
2025
Q3 		$135 Buy
+19
New +$138 ﹤0.01% 5182
2025
Q2 		– Sell
-2
Closed -$13 – 5360
2025
Q1 		$13 Buy
+2
New +$10 ﹤0.01% 5239
2024
Q1 		– Sell
-128
Closed -$734 – 5425
2023
Q4 		$734 Buy
+128
New +$570 ﹤0.01% 4786

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAIM
Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Fidelity Investments's DERM Position: Q2 2026 in Review

Fidelity Investments reduced its Journey Medical (DERM) stake by 78% in Q2 2026, selling an estimated $9.81K and leaving 476 shares worth $3.37K. The position accounts for ﹤0.01% of the portfolio, ranked #5088.

Fidelity Investments first reported a position in DERM in Q4 2023 and has held it in 6 quarters since. The position peaked at $10.3K in Q1 2026. 71 funds tracked by Wall St. Rank hold DERM as of Q2 2026.

  • Fidelity Investments held 476 shares of Journey Medical worth $3.37K as of Q2 2026.
  • Fidelity Investments sold 1,718 Journey Medical shares in Q2 2026, an estimated $9.81K.
  • Journey Medical made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #5088 holding.
  • Fidelity Investments first reported a position in Journey Medical in Q4 2023 and has held it in 6 quarters since.
  • Fidelity Investments's Journey Medical position peaked at $10.3K in Q1 2026.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.